Toll-Like Receptor 4 as a Favorable Prognostic Marker in Bladder Cancer: A Multi-Omics Analysis

BACKGROUND: The toll-like receptor 4 (TLR4) agonist, Bacille Calmette-Guérin, has exhibited gratifying effects in treating bladder cancer. The study aims to explore the expression pattern, prognostic value, and potential mechanism of TLR4 in bladder cancer. METHODS: The transcriptome file from the G...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jun-Lin, Xia, Qi-Dong, Sun, Yi, Xun, Yang, Hu, Heng-Long, Liu, Chen-Qian, Sun, Jian-Xuan, Xu, Jin-Zhou, Hu, Jia, Wang, Shao-Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204102/
https://www.ncbi.nlm.nih.gov/pubmed/34141706
http://dx.doi.org/10.3389/fcell.2021.651560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204102/
https://www.ncbi.nlm.nih.gov/pubmed/34141706
http://dx.doi.org/10.3389/fcell.2021.651560

Ejemplares similares